- Home
- PMNT vs PRTG Comparison
PMNT vs PRTG Comparison
Compare PMNT & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMNT
- PRTG
- Stock Information
- Founded
- PMNT 1984
- PRTG 1973
- Country
- PMNT United States
- PRTG British Virgin Islands
- Employees
- PMNT N/A
- PRTG N/A
- Industry
- PMNT
- PRTG Oil & Gas Production
- Sector
- PMNT
- PRTG Energy
- Exchange
- PMNT NYSE
- PRTG Nasdaq
- Market Cap
- PMNT 18.0M
- PRTG 17.7M
- IPO Year
- PMNT 2024
- PRTG N/A
- Fundamental
- Price
- PMNT $0.30
- PRTG $6.06
- Analyst Decision
- PMNT Strong Buy
- PRTG
- Analyst Count
- PMNT 1
- PRTG 0
- Target Price
- PMNT $6.00
- PRTG N/A
- AVG Volume (30 Days)
- PMNT 4.6M
- PRTG 233.8K
- Earning Date
- PMNT 08-13-2025
- PRTG 08-26-2025
- Dividend Yield
- PMNT N/A
- PRTG N/A
- EPS Growth
- PMNT N/A
- PRTG N/A
- EPS
- PMNT N/A
- PRTG N/A
- Revenue
- PMNT $21,501,000.00
- PRTG N/A
- Revenue This Year
- PMNT $52.76
- PRTG N/A
- Revenue Next Year
- PMNT N/A
- PRTG N/A
- P/E Ratio
- PMNT N/A
- PRTG N/A
- Revenue Growth
- PMNT N/A
- PRTG N/A
- 52 Week Low
- PMNT $0.22
- PRTG $2.10
- 52 Week High
- PMNT $2.15
- PRTG $23.01
- Technical
- Relative Strength Index (RSI)
- PMNT N/A
- PRTG 46.76
- Support Level
- PMNT N/A
- PRTG $5.25
- Resistance Level
- PMNT N/A
- PRTG $6.01
- Average True Range (ATR)
- PMNT 0.00
- PRTG 0.53
- MACD
- PMNT 0.00
- PRTG 0.11
- Stochastic Oscillator
- PMNT 0.00
- PRTG 55.14
About PMNT PERFECT MOMENT LTD
Perfect Moment Ltd is a company which is a luxury lifestyle brand that combines fashion and technical performance for its ranges of skiwear, outerwear, swimwear, and activewear. It operates at the intersection of luxury fashion and multi-channel commerce. Although the Company is organized fundamentally as one business segment which is product sales, the Company's revenues are primarily split between three geographic areas which are the U. S., Europe, and the UK.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.